Dr. Axe Wire · Study decoded · health
Could a Tree Compound Help Breast Cancer Drugs Work Again? Early Tests Say Maybe
A compound in Styrax obassia restored a circadian gene and resensitized resistant breast cancer cells to tamoxifen in lab tests.

- What they found: A compound from a tree found by screening 8,008 plant extracts restored a clock gene and helped resistant breast cancer cells respond to tamoxifen again.
- What it doesn't show: Whether it works the same way in people.
A compound called egonol, found in the tree Styrax obassia, restored sensitivity to the breast cancer drug tamoxifen in resistant cancer cells in a lab dish, according to a study published November 10, 2026 in Fitoterapia.
Working with human triple-negative breast cancer cells, researchers found a stem-like subgroup marked by high activity of an enzyme called ALDH (ALDHhigh) with sharply reduced CLOCK, a gene that helps run the body's internal clock. Restoring CLOCK brought back estrogen receptor-alpha, tamoxifen's target, and improved the drug response. To find a natural compound that could do this, the team screened 8,008 medicinal plant extracts using a reporter system tracking CLOCK activity. An extract from Styrax obassia raised CLOCK activity without killing the cells. Follow-up work isolated the active ingredient as egonol, a compound found in that tree.
According to the study authors, egonol works by suppressing a small RNA molecule called miR-3529-5p, which normally blocks CLOCK production. With that brake lifted, CLOCK and estrogen receptor-alpha rose, and the resistant cells responded better to tamoxifen. The authors describe this as a newly identified miR-3529-5p-CLOCK-estrogen receptor pathway tied to treatment resistance in this cell line, one piece of a larger picture of how these cells resist the drug.
Plant Extracts Screened
This work was done entirely in isolated human cancer cells in a lab dish, with no animal or human testing of egonol itself. The findings describe one resistant cell line and do not establish a dose, safety profile or effect in a living body.
Dr. Axe’s Take
A circadian clock gene called CLOCK helps determine whether these resistant breast cancer cells respond to tamoxifen, and a compound from Styrax obassia restored it in a lab dish. That mechanism is worth tracking as research moves toward animal models. For women in hormone-sensitive breast cancer treatment, I'd focus now on protecting your own circadian rhythm: consistent sleep and wake times, morning sunlight, and an earlier dinner, since that rhythm is the exact system this compound is trying to support. Keep taking tamoxifen or any prescribed therapy exactly as your oncologist has directed, and don't substitute any extract for it.
— Dr. AxeTake the Cellular Health Quiz →
Study summary
- Who
- Human MDA-MB-468 triple-negative breast cancer cells, including a stem-like, ALDH-high subgroup, studied in a lab dish.
- Design
- Lab screening of 8,008 medicinal plant extracts using a 3' UTR luciferase reporter, followed by fractionation to isolate the active compound, egonol.
- Dose
- Not reported; egonol tested as an isolated compound after fractionation from Styrax obassia extract, concentration not specified in the abstract.
- Primary result
- Egonol suppressed miR-3529-5p, restored CLOCK and estrogen receptor-alpha, and increased tamoxifen-induced growth inhibition in ALDH-high resistant cells; absolute effect size not reported.
- Secondary
- CLOCK overexpression alone restored estrogen receptor-alpha and improved tamoxifen sensitivity. Styrax obassia extract raised CLOCK reporter activity without cytotoxicity in screening.
- Funding / conflicts
- Funders listed in the journal record: AMED; Japan Society for the Promotion of Science. Competing interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
- Date
- Nov 10, 2026


